WO2000073454A1
(en)
*
|
1999-06-02 |
2000-12-07 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
WO2001034627A1
(en)
*
|
1999-11-12 |
2001-05-17 |
Human Genome Sciences, Inc. |
28 human secreted proteins
|
US20020137890A1
(en)
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7057017B2
(en)
|
1997-04-16 |
2006-06-06 |
Millennium Pharmaceuticals, Inc. |
Human dickkopf-related protein and nucleic acid molecules and uses therefor
|
US20030059780A1
(en)
|
1997-06-16 |
2003-03-27 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7446181B2
(en)
|
1998-01-15 |
2008-11-04 |
Millennium Pharmaceuticals, Inc. |
Antibodies that bind human Dickkopf-1 proteins
|
US20030149531A1
(en)
|
2000-12-06 |
2003-08-07 |
Hubert Rene S. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
ES2329851T3
(es)
|
1998-06-01 |
2009-12-01 |
Agensys, Inc. |
Nuevos antigenos transmembranables expresados en canceres humano y utilizacion de los mismos.
|
US6833438B1
(en)
|
1999-06-01 |
2004-12-21 |
Agensys, Inc. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
US20020172678A1
(en)
|
2000-06-23 |
2002-11-21 |
Napoleone Ferrara |
EG-VEGF nucleic acids and polypeptides and methods of use
|
US7264801B2
(en)
|
1998-08-11 |
2007-09-04 |
Genentech, Inc. |
EG-VEGF nucleic acids and polypeptides and method of use
|
US20030003507A1
(en)
|
1999-06-02 |
2003-01-02 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
US6344541B1
(en)
|
1998-09-25 |
2002-02-05 |
Amgen Inc. |
DKR polypeptides
|
CA2359132A1
(en)
|
1999-01-15 |
2000-07-20 |
Roxanne D. Duan |
Bone marrow-specific protein
|
US7034132B2
(en)
|
2001-06-04 |
2006-04-25 |
Anderson David W |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
CA2376404A1
(en)
*
|
1999-08-19 |
2001-03-01 |
Toshio Miyata |
Meg-1 protein
|
US7790861B2
(en)
*
|
1999-09-24 |
2010-09-07 |
Philadelphia Health And Education Corporation |
Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
|
US20020042062A1
(en)
|
1999-09-24 |
2002-04-11 |
Mark Stearns |
Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
|
US6762029B2
(en)
|
1999-12-23 |
2004-07-13 |
Portola Pharmaceuticals, Inc. |
Methods of identifying agents that modulate P2Y12 receptor activity
|
EP1263938A1
(de)
|
2000-02-11 |
2002-12-11 |
Henrik Clausen |
Udp-galactose: beta-d-galactose-r 4-alpha-galactosyltransferase, alpha4gal-t1
|
JP4342069B2
(ja)
*
|
2000-02-14 |
2009-10-14 |
生化学工業株式会社 |
α1,4−ガラクトース転移酵素およびそれをコードするDNA
|
US20020031815A1
(en)
*
|
2000-06-26 |
2002-03-14 |
Millennium Pharmaceuticals, Inc. |
46619, a novel human beta-ketoacyl synthase and uses thereof
|
AU6802801A
(en)
*
|
2000-03-01 |
2001-09-24 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
EP1698697A3
(de)
*
|
2000-03-24 |
2006-09-13 |
Takeda Pharmaceutical Company Limited |
SSD-enthaldentes Protein, Verfahren zu deren Herstellung und Verwendung
|
WO2001077169A2
(en)
*
|
2000-04-05 |
2001-10-18 |
Kirin Beer Kabushiki Kaisha |
Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
|
AU2001268967A1
(en)
*
|
2000-04-18 |
2001-10-30 |
Bayer Aktiengesellschaft |
Regulation of human epithin-like serine protease
|
EP1280917A2
(de)
*
|
2000-04-26 |
2003-02-05 |
Millennium Pharmaceuticals, Inc. |
21657, eine menschliche kurzketten-dehydrogenase und deren verwendungen
|
US7510845B2
(en)
|
2000-05-04 |
2009-03-31 |
California Institute Of Technology |
Assay employing G protein-coupled receptor expressed in dorsal root ganglia
|
US20030092035A1
(en)
|
2000-05-04 |
2003-05-15 |
Anderson David J. |
Pain signaling molecules
|
AU6740701A
(en)
*
|
2000-05-09 |
2001-11-20 |
Bayer Aktiengesellschaft |
Endothelial differentiation gene 6-like g protein coupled receptor
|
EP1311688A2
(de)
*
|
2000-05-26 |
2003-05-21 |
Millennium Pharmaceuticals, Inc. |
50250, eine humane lipase und deren verwendungen
|
WO2001096375A2
(en)
*
|
2000-06-16 |
2001-12-20 |
Millennium Pharmaceuticals, Inc. |
33358, a novel human ankyrin family member and uses thereof
|
WO2001098354A2
(en)
*
|
2000-06-21 |
2001-12-27 |
Incyte Genomics, Inc. |
Human receptors
|
AU2001281933A1
(en)
*
|
2000-06-30 |
2002-01-14 |
Ingenium Pharmaceuticals Ag |
Human g protein-coupled receptor igpcr17, and uses therof
|
AU2001281974A1
(en)
*
|
2000-07-13 |
2002-01-30 |
Novartis Ag |
Disease-associated gene
|
WO2002008392A2
(en)
*
|
2000-07-25 |
2002-01-31 |
Bayer Aktiengesellschaft |
Regulation of human matriptase-like serine protease
|
EP1315431A1
(de)
*
|
2000-08-02 |
2003-06-04 |
Millennium Pharmaceuticals, Inc. |
Ein mitglied der familie der menschlichen gtp-freisetzenden faktoren (15368) und dessen verwendung
|
AU2001283062A1
(en)
|
2000-08-02 |
2002-02-13 |
The Johns Hopkins University |
Endothelial cell expression patterns
|
JP2004525605A
(ja)
*
|
2000-08-04 |
2004-08-26 |
ルードヴィヒ インスティテュート フォー キャンサー リサーチ |
抑制遺伝子
|
EP1688496A3
(de)
*
|
2000-08-14 |
2006-08-16 |
Actimis Pharmaceuticals, Inc., |
Regulierung des menschlichen P2Y1-ähnlichen G-Protein gekoppelten Rezeptors
|
AU2001295454A1
(en)
*
|
2000-08-14 |
2002-02-25 |
Bayer Aktiengesellschaft |
Regulation of human p2y1-like g protein-coupled receptor
|
AU2001284902A1
(en)
*
|
2000-08-15 |
2002-02-25 |
Zymogenetics Inc. |
Human adenosine deaminase
|
WO2002016586A2
(en)
|
2000-08-21 |
2002-02-28 |
Bristol-Myers Squibb Company |
Adenosine deaminase homolog
|
US20030166300A1
(en)
*
|
2000-08-30 |
2003-09-04 |
Tang Y. Tom |
Growth-related inflammatory and immune response protein
|
WO2002018552A2
(en)
*
|
2000-08-30 |
2002-03-07 |
Bayer Aktiengesellschaft |
Regulation of human aminotransferase-like enzyme
|
US20040072185A1
(en)
*
|
2000-09-15 |
2004-04-15 |
Patrizia Paterlini-Brechot |
Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses
|
US7754435B2
(en)
*
|
2000-09-21 |
2010-07-13 |
Philadelphia Health And Education Corporation |
Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
|
AU2002211502A1
(en)
*
|
2000-10-04 |
2002-04-15 |
Curagen Corporation |
Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
|
AU2002220613A1
(en)
*
|
2000-10-11 |
2002-04-22 |
Bayer Aktiengesellschaft |
Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase
|
AU2001297794A1
(en)
|
2000-10-19 |
2002-12-03 |
Millenium Pharmaceuticals, Inc. |
Methods and compositions of human proteins and uses thereof.
|
MXPA03003902A
(es)
|
2000-11-03 |
2004-04-02 |
Univ California |
Polipeptidos de proquineticina, composiciones relacionadas y metodos.
|
AU2001297575A1
(en)
*
|
2000-11-08 |
2002-10-08 |
Millennium Pharmaceuticals, Inc. |
38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
|
DE60142804D1
(de)
*
|
2000-11-09 |
2010-09-23 |
Univ Virginia |
Menschliche hodenspezifische Serin/Threonin-Kinase
|
AU2002229011A1
(en)
*
|
2000-11-09 |
2002-05-21 |
Glaxo Group Limited |
Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp
|
US7312086B2
(en)
|
2000-12-07 |
2007-12-25 |
Bristol-Myers Squibb Company |
Methods of diagnosing colon adenocarcinoma using the human g-protein coupled receptor hgprbmy23
|
WO2002050279A2
(en)
*
|
2000-12-21 |
2002-06-27 |
Incyte Genomics, Inc. |
Nucleic acid-associated proteins
|
US7892730B2
(en)
*
|
2000-12-22 |
2011-02-22 |
Sagres Discovery, Inc. |
Compositions and methods for cancer
|
US20030148920A1
(en)
*
|
2000-12-27 |
2003-08-07 |
Steven Rosen |
Sulfatases and methods of use thereof
|
WO2002053719A2
(en)
*
|
2001-01-04 |
2002-07-11 |
Incyte Genomics, Inc. |
Cytoskeleton-associated proteins
|
US20040126759A1
(en)
*
|
2001-01-05 |
2004-07-01 |
Baughn Mariah R. |
Molecules for disease detection and treatment
|
US6319679B1
(en)
*
|
2001-01-26 |
2001-11-20 |
Board Of Regents, The University Of Texas System |
PAS kinase
|
US20020115136A1
(en)
*
|
2001-02-07 |
2002-08-22 |
Gennady Merkulov |
Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
|
AU2002247716A1
(en)
*
|
2001-02-14 |
2002-08-28 |
Axaron Bioscience Ag |
Proteins 7b6 and 11b4 and dna sequences encoding the same
|
CA2440272A1
(en)
*
|
2001-03-16 |
2002-09-26 |
Incyte Genomics, Inc. |
Nucleic acid-associated proteins
|
US20030044813A1
(en)
*
|
2001-03-30 |
2003-03-06 |
Old Lloyd J. |
Cancer-testis antigens
|
US20020146795A1
(en)
*
|
2001-04-02 |
2002-10-10 |
Shiaoping Zhu |
Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
|
US7927597B2
(en)
*
|
2001-04-10 |
2011-04-19 |
Agensys, Inc. |
Methods to inhibit cell growth
|
WO2002083921A2
(en)
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
US6962811B2
(en)
|
2001-05-09 |
2005-11-08 |
Millennium Pharmaceuticals, Inc. |
14715, a human fringe family member nucleic acids and uses therefor
|
CN100463967C
(zh)
|
2001-05-29 |
2009-02-25 |
人体细胞组织有限公司 |
睾丸肉碱转运蛋白及其基因
|
ATE483976T1
(de)
|
2001-06-05 |
2010-10-15 |
Exelixis Inc |
Gfats als modifikatoren des p53-wegs und verwendungsverfahren
|
EP1992643A3
(de)
*
|
2001-06-20 |
2008-12-10 |
Genentech, Inc. |
Zusammensetzungen und Verfahren zur Behandlung und Diagnose von Tumoren
|
WO2003000874A2
(en)
*
|
2001-06-25 |
2003-01-03 |
Bayer Aktiengesellschaft |
Regulation of human serine/threonine protein kinase nek3
|
AU2002336446B2
(en)
*
|
2001-09-06 |
2008-03-06 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer
|
US7494646B2
(en)
|
2001-09-06 |
2009-02-24 |
Agensys, Inc. |
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
|
ATE350667T1
(de)
*
|
2001-09-24 |
2007-01-15 |
Gruenenthal Gmbh |
Screeningverfahren für verschiedene indikationen mit dnpi
|
US7265214B2
(en)
|
2001-10-19 |
2007-09-04 |
Rigel Pharmaceuticals, Inc. |
Germinal center kinase proteins, compositions and methods of use
|
AU2002349924A1
(en)
*
|
2001-10-29 |
2003-05-12 |
Millennium Pharmaceuticals, Inc. |
32235, a human aminotransferase family member and uses therefor
|
WO2003038128A1
(en)
*
|
2001-10-31 |
2003-05-08 |
Millennium Pharmaceuticals, Inc. |
Methods and compositions for the treatment and diagnosis of pain disorders using 57749
|
EP1439864A4
(de)
|
2001-10-31 |
2004-12-22 |
Millennium Pharm Inc |
Verfahren zur behandlung und diagnose tumorigener und angiogener störungen unter verwendung von 32616
|
EP1310552B1
(de)
|
2001-11-09 |
2007-06-13 |
Proteologics, Inc. |
Posh Nukleinsäure, Polypeptide und darauf bezogene Verfahren
|
AU2002360460A1
(en)
*
|
2001-12-03 |
2003-06-17 |
Nuvelo, Inc. |
Methods and materials relating to novel polypeptides and polynucleotides
|
US20050004056A1
(en)
*
|
2001-12-04 |
2005-01-06 |
Martin Meise |
Ptp10d, tec protein tyrosine kinase and edtp homologous proteins involved in the regulation of energy homeostasis
|
AU2002357163A1
(en)
*
|
2001-12-12 |
2003-07-09 |
University Of Cincinnati |
Apyrase polypeptides and nucleic acids encoding same
|
US7858297B2
(en)
*
|
2001-12-18 |
2010-12-28 |
Centre National De La Recherche Scientifique Cnrs |
Chemokine-binding protein and methods of use
|
ES2337989T3
(es)
|
2001-12-18 |
2010-05-03 |
Endocube Sas |
Nuevas proteinas asociadas a la muerte de la familia thap y rutas par4 relacionadas implicadas en el control de la apoptosis.
|
AU2003244347A1
(en)
*
|
2002-02-04 |
2003-09-02 |
Takeda Chemical Industries, Ltd. |
Angiogenesis inhibitors
|
GB0205112D0
(en)
*
|
2002-03-05 |
2002-04-17 |
Pantherix Ltd |
Enzyme
|
WO2003076072A1
(fr)
|
2002-03-11 |
2003-09-18 |
Japan Science And Technology Agency |
Catalyseur de zirconium chiral pratique
|
DE10212397A1
(de)
|
2002-03-20 |
2003-10-16 |
Universitaetsklinikum Freiburg |
Repressor der Skelettmuskeldifferenzierung, dafür kodierende Nucleinsäure und dessen Verwendung in Diagnostik und Therapie
|
WO2003086462A1
(fr)
*
|
2002-03-29 |
2003-10-23 |
Celestar Lexico-Sciences,Inc. |
Inhibiteurs de phosphorylation c-jun
|
US20050202431A1
(en)
*
|
2002-04-01 |
2005-09-15 |
National Institute Of Advanced Industrial Science |
Application of kiaa0172 gene to treatment and diagnosis of diseases and drug discovery
|
US7622443B2
(en)
|
2002-04-26 |
2009-11-24 |
California Institute Of Technology |
Method for inhibiting pro-angiogenic activities of endothelial cells selectively at a site of neoangiogenesis in a mammal by administration of the extracellular domain of D1-1 polypeptides
|
AU2003234274A1
(en)
|
2002-04-26 |
2003-11-10 |
California Institute Of Technology |
D1-1 nucleic acids, polypeptides and related methods
|
DE10222845A1
(de)
*
|
2002-05-23 |
2003-12-04 |
Dresden Arzneimittel |
Klonierung, Expression und Charakterisierung der Gesamtsequenz von Phosphodiesterase 8B
|
EP1572952B1
(de)
*
|
2002-06-28 |
2010-09-29 |
Imclone LLC |
Neue polynukleotid- und polypeptidsequenzen und deren verwendungen
|
US7135556B2
(en)
|
2002-07-19 |
2006-11-14 |
Schering Corporation |
NPC1L1 (NPC3) and methods of use thereof
|
EP1525311A2
(de)
*
|
2002-07-19 |
2005-04-27 |
Cellzome Ag |
Proteinkomplexe des transkriptionellen aktivatorproteins tip60
|
JP2004290170A
(ja)
*
|
2002-08-02 |
2004-10-21 |
Takeda Chem Ind Ltd |
疾患関連遺伝子の用途
|
TW200413725A
(en)
*
|
2002-09-30 |
2004-08-01 |
Oncotherapy Science Inc |
Method for diagnosing non-small cell lung cancers
|
US7056685B1
(en)
|
2002-11-05 |
2006-06-06 |
Amgen Inc. |
Receptor ligands and methods of modulating receptors
|
US20080213166A1
(en)
*
|
2002-11-20 |
2008-09-04 |
Biogen Idec Inc. |
Novel Gene Targets and Ligands that Bind Thereto for Treatment and Diagnosis of Colon Carcinomas
|
CA2507924A1
(en)
*
|
2002-12-10 |
2004-07-01 |
Endocube Sas |
Thap proteins as nuclear receptors for chemokines and roles in transcriptional regulation, cell proliferation and cell differentiation
|
JP4140951B2
(ja)
*
|
2002-12-18 |
2008-08-27 |
独立行政法人科学技術振興機構 |
転写制御因子zhx3
|
JP3955885B2
(ja)
|
2002-12-29 |
2007-08-08 |
日産化学工業株式会社 |
アディポネクチン受容体及びそれをコードする遺伝子
|
EP1585815A4
(de)
*
|
2003-01-21 |
2006-02-22 |
Bristol Myers Squibb Co |
Ein neues acyl-coenzym a, monoacylglycerin-acyltransferase-3 (mgat3), codierendes polynukleotid sowie verwendungen davon
|
CN1747744B
(zh)
*
|
2003-02-03 |
2011-07-27 |
独立行政法人科学技术振兴机构 |
使用otx2基因再生和新生视网膜感光细胞
|
CA2518101A1
(en)
*
|
2003-03-03 |
2005-06-09 |
Genentech, Inc. |
Compositions and methods for the treatment of systemic lupus erythematosis
|
EP1622571A4
(de)
*
|
2003-04-30 |
2012-05-02 |
Agensys Inc |
Nucleinsäuren und entsprechende proteine mit der bezeichnung 109p1d4 zur behandlung und zum nachweis von krebs
|
WO2004104218A1
(en)
*
|
2003-05-23 |
2004-12-02 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with x-prolyl aminopeptidase (aminopeptidase p) 1 (xpnpep1)
|
WO2005023855A2
(en)
*
|
2003-09-10 |
2005-03-17 |
Friedrich-Alexander-Uni- Versitatet Erlangen- Nuernberg |
K203 gene and protein
|
WO2005030953A1
(ja)
*
|
2003-09-30 |
2005-04-07 |
Daiichi Pharmaceutical Co., Ltd. |
テトラヒドロ葉酸合成酵素遺伝子
|
WO2005059504A2
(en)
*
|
2003-12-12 |
2005-06-30 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with g protein-coupled receptor gpr34 (gpr34)
|
MXPA06008124A
(es)
|
2004-01-16 |
2007-01-26 |
Merck & Co Inc |
Npc1l1 (npc3) y metodos para identificar ligandos del mismo.
|
CA2555675A1
(en)
*
|
2004-02-10 |
2005-08-25 |
Trustees Of Dartmouth College |
Nicotinamide riboside kinase compositions and methods for using the same
|
US8055347B2
(en)
|
2005-08-19 |
2011-11-08 |
Brainsgate Ltd. |
Stimulation for treating brain events and other conditions
|
US8010189B2
(en)
|
2004-02-20 |
2011-08-30 |
Brainsgate Ltd. |
SPG stimulation for treating complications of subarachnoid hemorrhage
|
US9233245B2
(en)
|
2004-02-20 |
2016-01-12 |
Brainsgate Ltd. |
SPG stimulation
|
WO2005089505A2
(en)
|
2004-03-19 |
2005-09-29 |
Yale University |
Detection, isolation and uses of renalase (monoamine oxidase c)
|
EP2289911A3
(de)
|
2004-03-30 |
2011-03-30 |
NsGene A/S |
Therapeutische Verwendung des Wachstumsfaktors nsg33
|
US20050222040A1
(en)
*
|
2004-04-05 |
2005-10-06 |
Blm Group, Inc. |
Vertebrate peptide modulators of lipid metabolism
|
ES2443996T3
(es)
|
2004-04-22 |
2014-02-21 |
Agensys, Inc. |
Anticuerpos y moléculas derivadas de los mismos que se unen a proteínas STEAP-1
|
WO2006015373A2
(en)
|
2004-08-04 |
2006-02-09 |
Amgen Inc |
Antibodies to dkk-1
|
WO2006069592A2
(en)
*
|
2004-12-31 |
2006-07-06 |
Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg |
Method for diagnosing an/or predicting preeclampsia and/or related disorders
|
FI20050011A
(fi)
*
|
2005-01-05 |
2006-07-06 |
Jurilab Ltd Oy |
Menetelmä ja testipakkaus tyypin 2 diabetes mellituksen riskin havaitsemiseksi
|
WO2006074914A2
(en)
*
|
2005-01-13 |
2006-07-20 |
Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research |
Human rna helicase and therapeutic uses thereof
|
US7521195B1
(en)
|
2005-07-21 |
2009-04-21 |
Celera Corporation |
Lung disease targets and uses thereof
|
US7858084B2
(en)
|
2005-11-21 |
2010-12-28 |
Yale University |
Methods of treatment with renalase (monoamine oxidase C)
|
US9206242B2
(en)
*
|
2005-11-22 |
2015-12-08 |
National University Corporation Nagoya University |
Application of actin-binding protein to disease associated with cell motility
|
US7910698B2
(en)
|
2006-02-24 |
2011-03-22 |
Schering Corporation |
NPC1L1 orthologues
|
SI2502938T1
(sl)
|
2006-10-27 |
2015-05-29 |
Genentech, Inc. |
Protitelesa in imunokonjugati in njihove uporabe
|
US7960345B2
(en)
*
|
2007-05-02 |
2011-06-14 |
Snu R&Db Foundation |
Angiogenesis inhibitor comprising meteorin as an active ingredient
|
CA2691378A1
(en)
|
2007-07-02 |
2009-01-08 |
Oncomed Pharmaceuticals, Inc. |
Antibody against human r-spondin (rspo) and use thereof for inhibition of beta-catenin signaling and treatment of cancer
|
WO2009003694A2
(en)
*
|
2007-07-03 |
2009-01-08 |
Andreas Reichert |
Method for treating diseases related to mitochondrial dysfunction
|
US20100204128A1
(en)
*
|
2007-07-24 |
2010-08-12 |
Sanare Investment As |
Novel peptides
|
WO2009083502A1
(en)
|
2007-12-28 |
2009-07-09 |
Novo Nordisk A/S |
Ddr1-mediated cell purification of pancreatic endocrine cells through their progenitors
|
CA2730710C
(en)
|
2008-07-24 |
2021-06-08 |
Nsgene A/S |
Therapeutic use of a growth factor, metrnl
|
CA2755784C
(en)
|
2009-03-16 |
2020-03-24 |
Pangu Biopharma Limited |
Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities
|
AR075989A1
(es)
|
2009-04-10 |
2011-05-11 |
Lilly Co Eli |
Anticuerpo dkk -1 (dickkopf-1) humano disenado por ingenieria
|
US8815779B2
(en)
|
2009-09-16 |
2014-08-26 |
SwitchGear Genomics, Inc. |
Transcription biomarkers of biological responses and methods
|
AR079217A1
(es)
|
2009-11-30 |
2012-01-04 |
Genentech Inc |
Composiciones y metodos para el diagnostico y el tratamiento de tumores
|
ES2535951T3
(es)
|
2009-12-11 |
2015-05-19 |
Atyr Pharma, Inc. |
Histidil ARNt sintetasas para reducir la inflamación
|
EP2566492B1
(de)
|
2010-05-04 |
2016-10-26 |
aTyr Pharma, Inc. |
Innovative entdeckung therapeutischer zusammensetzungen im zusammenhang mit proteinfragmenten von glutamyl-prolyl-trna-synthetasen
|
US20130202576A1
(en)
|
2010-07-12 |
2013-08-08 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
|
CN103269708A
(zh)
|
2010-10-01 |
2013-08-28 |
Ns基因公司 |
镍纹蛋白用于治疗异常性疼痛、痛觉过敏、自发性疼痛和幻痛的用途
|
WO2013012747A1
(en)
|
2011-07-15 |
2013-01-24 |
Oncomed Pharmaceuticals, Inc. |
Rspo binding agents and uses thereof
|
US9474786B2
(en)
|
2011-09-05 |
2016-10-25 |
Nsgene A/S |
Treatment of allodynia
|
RU2659423C2
(ru)
|
2012-02-16 |
2018-07-02 |
ЭйТИР ФАРМА, ИНК. |
ГИСТИДИЛ-тРНК-СИНТЕТАЗЫ ДЛЯ ЛЕЧЕНИЯ АУТОИММУННЫХ И ВОСПАЛИТЕЛЬНЫХ ЗАБОЛЕВАНИЙ
|
JP6335896B2
(ja)
|
2012-07-13 |
2018-05-30 |
オンコメッド ファーマシューティカルズ インコーポレイテッド |
Rspo3結合剤およびその使用法
|
EP2742935A1
(de)
*
|
2012-12-14 |
2014-06-18 |
Tissue Med Biosciences Forschungs- und Entwicklungsgesellschaft mbH |
SERF2 für die Atrophiebehandlung oder Steigerung des Zellwachstums
|
DK3460054T3
(da)
|
2013-03-15 |
2021-01-18 |
Atyr Pharma Inc |
Histidyl-tRNA-syntetase-Fc-konjugater
|
EP2878335B1
(de)
|
2013-11-10 |
2018-01-03 |
Brainsgate Ltd. |
Implantat und implantationssystem für nervenstimulator
|
US10064937B2
(en)
|
2014-09-16 |
2018-09-04 |
Oncomed Pharmaceuticals, Inc. |
Treatment of dermal fibrosis
|
US10271907B2
(en)
|
2015-05-13 |
2019-04-30 |
Brainsgate Ltd. |
Implant and delivery system for neural stimulator
|
EP3548039B1
(de)
|
2016-12-04 |
2023-07-19 |
Alavi Khorassani Moghadam, Marcel Victor |
Ribavirin zur verwendung bei der behandlung einer mitochondriellen erkrankung
|
WO2018176065A1
(en)
*
|
2017-03-23 |
2018-09-27 |
Oregon State University |
Therapeutic compositions and methods for treatment of muscle wasting diseases
|
BR112019018767A2
(pt)
|
2017-04-03 |
2020-05-05 |
Hoffmann La Roche |
anticorpos, molécula de ligação ao antígeno biespecífica, um ou mais polinucleotídeos isolados, um ou mais vetores, célula hospedeira, método para produzir um anticorpo, composição farmacêutica, usos, método para tratar uma doença em um indivíduo e invenção
|
JP2020517638A
(ja)
|
2017-04-20 |
2020-06-18 |
エータイアー ファーマ, インコーポレイテッド |
肺の炎症を治療するための組成物および方法
|
CN110910960B
(zh)
*
|
2019-11-30 |
2022-07-08 |
浙江天科高新技术发展有限公司 |
一种鲍曼不动杆菌分子血清型快速分析方法
|
AU2021394748A1
(en)
*
|
2020-12-08 |
2023-06-08 |
Imagine Pharma Llc |
Compositions and methods for treating wounds
|